What We're Reading: Page 280
Industry reads hand-picked by our editors
Jan 25, 2018
-
Kaiser Health News
Big pharma greets hundreds of ex-federal workers at the ‘revolving door’
-
Bloomberg
Puma plunges as cancer drug setback stuns Wall Street
-
Salon
With macaque monkey cloning, China emerges as a new leader in cloning biotech
-
Scientific American
The pharma exec behind the first approved gene therapy is hunting for his next big break
Jan 24, 2018
-
Kaiser Health News
University under fire for off-the-grid herpes vaccine experiments
-
Science
NIH’s new clinical trial policy kicks in despite concerns from basic behavioral researchers
-
Bloomberg
China pharma tycoon mulls $500 million IPO of clinic arm
-
The Tennessean
Big pharma likes to treat opioid addiction with medication. Is that a problem?
Jan 23, 2018
-
Financial Times
Big pharma makes strongest start to M&A for a decade
-
Xconomy
Tmunity reels in $100M for “next generation” cancer immunotherapy
-
The Wall Street Journal
China, unhampered by rules, races ahead in gene-editing trials
Jan 22, 2018
Jan 19, 2018
-
Los Angeles Times
We're underfunding research on vaccines that may be able to prevent another terrible flu season
-
CNBC
This start-up founder has a novel strategy for getting ahead: Telling the truth
-
Business Insider
'We're not going to follow the hype': Biotech VCs are concerned by the staggering size of early-stage startup funding
Jan 18, 2018
-
The Wall Street Journal
Judge signals he will approve $290 million settlement between Allergan shareholders and Pershing, Valeant
-
MIT Technology Review
U.S. doctors plan to treat cancer patients using CRISPR
-
Healthcare Dive
Study finds limited evidence that remote patient monitoring improves outcomes
-
Politico
Senate committee advances Trump's nominee for HHS secretary
-
Retail Dive
Walmart to give away opioid disposal kits
Jan 17, 2018
-
The Wall Street Journal
Celgene in talks to buy Juno Therapeutics
-
Bloomberg
Biotech ETF leaks cash as hopes for more M&A fizzle
-
Nature
Biotech booms in China